XML 20 R1.htm IDEA: XBRL DOCUMENT v3.25.0.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 04, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Document Transition Report false    
Entity Registrant Name CUMBERLAND PHARMACEUTICALS INC    
Entity Incorporation, State or Country Code TN    
Entity Tax Identification Number 62-1765329    
Entity File Number 001-33637    
Entity Central Index Key 0001087294    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Address, Address Line One 1600 West End Avenue    
Entity Address, Address Line Two Suite 1300    
Entity Address, City or Town Nashville    
Entity Address, State or Province TN    
Entity Address, Postal Zip Code 37203    
City Area Code 615    
Local Phone Number 255-0068    
Title of 12(b) Security Common Stock, $0.00 par value per share    
Trading Symbol CPIX    
Security Exchange Name NASDAQ    
Entity Filer Category Non-accelerated Filer    
Entity Emerging Growth Company false    
Entity Small Business true    
Entity Shell Company false    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Public Float     $ 12,234,822
Entity Common Stock, Shares Outstanding   13,968,394  
Document Financial Statement Error Correction false    
Documents Incorporated by Reference
Certain information required in Part III of Form 10-K is incorporated by reference from the registrant’s Proxy Statement for its 2025 annual meeting of shareholders.